AMNEAL PHARMACEUTICALS, INC. Insider Trading Arrangements
Rule 10b5-1 and other trading arrangements that directors and officers adopted or terminated, as each 10-Q and 10-K tags them (Item 408(a)), newest report first.
- 2025-11-06: Individual Deborah Autor; Title a director; Arrangement Rule 10b5-1; Adopted September 5, 2025.
- 2024-11-12: Individual Gautam Patel; Title a director; Arrangement Rule 10b5-1; Adopted August 15, 2024.
| Report filed | Individual | Title | Arrangement | Adopted | Terminated | Expires or duration | Securities covered |
|---|---|---|---|---|---|---|---|
| 2025-11-06 10-Q | Deborah Autor | a director | Rule 10b5-1 | September 5, 2025 | December 31, 2026. P482D | 34,819 | |
| 2024-11-12 10-Q | Gautam Patel | a director | Rule 10b5-1 | August 15, 2024 | June 30, 2025 P319D | 480,000 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |